Latest Sirolimus Stories
There’s the saying, “An apple a day, keeps the doctor away.” For cancer patients, it might be lucrative to drink grapefruit juice instead.
Scientists at UC Santa Barbara have demonstrated in the laboratory that a new drug is effective in treating a very common kidney disease –– although it will be a few years before it becomes available for clinical testing.
Rapamycin, an immunosuppressant typically used to prevent rejection in organ transplants, could help prevent diminishing cognitive skills, including memory retention, associated with aging or Alzheimer's disease.
Johns Hopkins scientists have engineered cells that behave like AND and OR Boolean logic gates, producing an output based on one or more unique inputs.
A phase I clinical trial examining the safety of combining temsirolimus and capecitabine in advanced malignancies suggests the two agents can be given safely to patients.
- A political dynamiter.